1295786
Wyeth Pharmaceutical Division of Wyeth Holdings LLC — FEI 2410662
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 17, 2025
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Pearl River, NY (United States)
Citations
| ID | CFR | Description |
| 1452 | 21 CFR 211.113(b) | Validation lacking for sterile drug products |
| 1803 | 21 CFR 211.84(b) | Representative Samples Criteria |
| 2399 | 21 CFR 211.194(a)(2) | Laboratory Test Method Verification |
| 4320 | 21 CFR 211.84(d)(6) | Microbiological Contamination Exam |